AMBU A/S
CVR: 63644919
Secondary names: TESTA-LABORATORIUM A/S, AMBU INTERNATIONAL A/S, MEDICOTEST A/S
AMBU A/S demonstrates a strong financial position with a notable increase in revenue and profit, reporting 6.04 billion DKK in revenue and 609 million DKK in profit for 2025, up from 5.39 billion DKK in revenue and 235 million DKK in profit in 2024. The company's equity stands robust at 6.04 billion DKK, indicating a solid foundation for future growth. However, the lack of detailed financial data for previous years raises concerns about the consistency of its performance. Positioned within the medical supplies industry, AMBU A/S is well-placed to capitalize on ongoing healthcare demands, but its ability to maintain profit margins amidst market fluctuations will be crucial for its trajectory.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er at drive fabrikation og handel fortrinsvis indenfor medicoteknik samt anden i forbindelse hermed stående virksomhed i ind- og udland Selskabet kan som aktionær og/ eller som interessent ved investering, lån og kreditgivning have interesse i andre selskaber eller virksomheder indenfor samme formål som angivet ovenfor.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 6 mia. | 609 mio. | 7.7 mia. | 6 mia. | 5233 | |
History
Management
Directors
Board
Production units (3)
Similar companies
Companies in the same industry and area